Oxidative stress in vascular dementia and Alzheimer’s disease: a common pathology
The DOI matches its Crossref record.
Abstract
Alzheimer's disease and vascular dementia are the two most common types of dementia with the former being the most predominant. It is evident that oxidative stress, an environment where pro-oxidant species overwhelm antioxidant species, is involved in the pathogenesis of both forms of dementia. An increased level of reactive oxygen species in the vasculature, reduced nitric oxide bioavailability, and endothelial dysfunction leading to vascular disease is associated with vascular dementia. In Alzheimer's disease, an increased amount of amyloid-beta peptide induces elevated reactive oxygen species production thereby causing neuronal cell death and damage. The recent observation that increased atherosclerotic plaque formation is present in the main artery to the brain in Alzheimer's disease, coupled with the association of vascular risk factors with this disease, suggests a link between these two dementias. This review will argue that Alzheimer's disease and vascular dementia are two extremes of one disease, thus assuming a hypothesis where the clinical conditions referred to as dementia are part of a continuum. We propose that the majority of cases share a vascular pathology and that oxidative stress is central to this common pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these factors, oxidative stress has been shown to be involved in AD pathogenesis [64], [65].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [64]
In the citing paper
“Oxidative stress associated with Aβ pathology plays an important role in the death of neurons in the AD brain [82,83,84,85].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [83]
Citations
Cites
Still being checked.
Cited by
Items 201–253 of 253
Amin, M. A., Zehravi, M., Sweilam, S. H., Shanmugarajan, T. S., Arjun, U. V. N. V., Nagaiyan, M. B., Reddy, S. M., Subash, V., swarnalatha, K. M., Pazhanikumar, A., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04470-8 · Cited by 4
Jin, Y., Lin, H., Ye, Z., Wang, H., Liu, Y., Qiu, W., & Liu, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241300354 · Cited by 4
Yuliani, S., & Linar, N. (2019) · Ahmad Dahlan International Conference Series on Pharmacy and Health Science (ADICS-PHS) · doi:10.2991/adics-phs-19.2019.12 · Cited by 4
Yang, Y., Xu, L., Yao, X., Wang, Y., Fang, M., Zhou, D., Li, N., & Hou, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113366 · Cited by 3
Sun, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5387 · Cited by 3
Risk of Dementia in Patients with Leptospirosis: A Nationwide Cohort Analysis
Chiu, C.-H., Chen, P.-C., Wang, Y.-C., Lin, C., Lee, F.-Y., Wu, C., & Chang, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173168 · Cited by 7
Chen, J., Chen, J., Liang, C., Liu, C., Liu, J., Liu, B., & Yang, X. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.67 · Cited by 2
Wang, Z., Xu, S., Lin, A., Wei, C., Li, Z., Chen, Y., Bie, B., & Liu, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331787 · Cited by 3
Ebrahim, L. K., Adel, S., Hamza, S. A., Alsadany, M. A., & Ali, S. M. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00847-3 · Cited by 2
Oxidative stress and antioxidant protection in disorders of cerebral circulation
Tanashyan, M. М., & Maksimova, M. Y. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2024124121114 · Cited by 2
Sairaj, V., Poovethamkandiyil, A. S., Hinder, S. J., Pillai, S. C., & Vijayan, B. K. (2025) · New Journal of Chemistry · doi:10.1039/d4nj05040a · Cited by 2
Research on the Effects of Vitamins and Minerals on Cognitive Function in Older Adults
de Jager, C. A., & Ahmed, S. (2015) · CRC Press eBooks · doi:10.1201/b18563-12 · Cited by 2
The neuron navigator 2 gene and Alzheimer's disease
Xu, C. D., Su, B., Lozano, S., & Wang, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00001-3 · Cited by 2
Parietal matters in early Alzheimer's disease : evidence from structural and functional MRI
Jacobs, H. I. L. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110706hj · Cited by 1
Radošinská, D., Kollárová, M., Shawkatová, I., Ďurmanová, V., Párnická, Z., Javor, J., Brandoburová, P., Harsányi, Š., & Radošinská, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188790 · Cited by 1
Huang, X., Liu, J., Ren, Y., Liu, D., Cai, J., Cao, L., Lei, T., & Wu, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1719664 · Cited by 1
Parkinson’s disease dementia and hearing impairment, are they related? A UK biobank pilot analysis
Readman, M. R., Giebel, C. M., Cannon, J., Fairman, I., & Plack, C. J. (2026) · Experimental Brain Research · doi:10.1007/s00221-026-07282-1 · Cited by 1
Correlations Between Thyroid Stimulating Hormone (TSH) and Oxidative Stress in Mixed Dementia
Persa, O. D. (2013) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2013.161 · Cited by 3
Hatanaka, H., Hirose, D., Hirao, K., Shimizu, S., Kanetaka, H., & Hanyu, H. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12989 · Cited by 1
Leppien, E. E., & Demler, T. L. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000224 · Cited by 1
Dantas, L. P., Vasconcelos, E. C., Cunha, C., Batista, P. V. C., Torres, M. C. S., de Sousa, C. N. S., de Aquino, G. Â., Junior, M. A. D. S., de Rezende, P. H. F., de Vasconcelos, W. S., et al. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01586-x · Cited by 1
Neurocognitive and Neuropsychological Effects of OSA
Spector, A. R., & Farrer, T. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-54146-0_4 · Cited by 1
Rout, S., Rath, B., Bhattamisra, S. K., Rath, I., & Kumar, A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i47b33122 · Cited by 1
Research progress on the mechanism of acupuncture treatment for vascular dementia
Sun, W., Chen, Y., Liu, T., Su, X., & Qin, R. (2024) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2024.06.001 · Cited by 1
Salazar, J. G., Marsillach, J., Reverte, I., Mackness, B., Mackness, M., Joven, J., Camps, J., & Colomina, M. T. (2021) · Antioxidants · doi:10.3390/antiox10030339 · Cited by 28
Blutbasierte Mikrozirkulationsmarker bei der Alzheimer-Demenz
Knauer, K. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12369
Oralhealthstatusinrelation tocognitivefunctionamong older
Iwasaki, M., Yoshihara, A., Ogawa, H., Yamaga, T., Sato, M., Wada, T., Sakamoto, R., Ishimoto, Y., Fukutomi, E., Chen, W., et al. (2015)
Antioxidant Status in Vascular Dementia
Zito, G., Squitti, R., & Polimanti, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00049-5
The effect of vascular risk factors in dementia of the Alzheimer's type
Restrepo, C. (2016) · Minerva Access (University of Melbourne)
Ali, A. A., & Ali, A. A. (2017) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000241
Neurodegenerative Disorders Progression: From Synaptic Dysfunction to Transmission Failure
Kaur, R., Kaur, H., Rajput, R., Kumar, S., Rachana, R., & Singh, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch006
Neurochemical Aspects of Vascular Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00005-2 · Cited by 1
Editorial: Oxidative Stress in Myocardial and Neural Remodeling
Nguyen, T. P., Frautschy, S. A., & Eghbali, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.606484
Pharmacological Approaches in the Augmentation and Recovery of Brain Function
Muresanu, D. F., Bîrle, C., Popa, L. L., Verișezan-Roșu, O., & Strilciuc, Ș. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-54564-2_30
Chandra, S., & Toppo, A. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_539_20 · Cited by 1
Huang, C.-H., Lin, M., Chou, I., & Hsieh, C. (2021) · Research Square · doi:10.21203/rs.3.rs-910563/v1
Research Progress of Blood Biochemical Indicators in Patients with Early Diabetic Kidney Disease
路, 会. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125563
The Clinical Research Progress in Vascular Cognitive Impairment
方, 咏. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142421
Alzheimer’s Disease and Related Dementias: A Review of Evidence for Clinical Exercise Physiologists
Bruneau, M. L., & Perry, B. (2024) · Journal of Clinical Exercise Physiology · doi:10.31189/2165-6193-13.1.24
Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan
Lee, S., Lee, Y., Chung, C., Chien, W., Li, S.-T., Yao, C.-Y., & Tzeng, N. (2024) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2024-005408 · Cited by 2
Asioli, F. (2024) · RIVISTA SPERIMENTALE DI FRENIATRIA · doi:10.3280/rsf2024-002002
Nitric oxide-mediated neuroinflammatory pathways as treatment targets in neurodegeneration
Cale, J. A., Farr, T. D., Serres, S., & Steinert, J. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22354-9.00005-x
Küçükkarapınar, M., & Reuter, H. (2025) · Studies in natural products chemistry · doi:10.1016/b978-0-443-23752-2.00010-4
Johnson, N. (2025) · The Conversation · doi:10.64628/aai.tjyxc5et9
Johnson, N. (2025) · The Conversation · doi:10.64628/ade.c5yt6e9j6
Piñol, M. S. (2009) · TDX (Tesis Doctorals en Xarxa)
Wang, L., Zhao, T., Zhu, X., & Jiang, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26579381
Bao, Q., Xia, M.-Z., Xiong, J., Liu, Y.-W., Li, Y.-Q., Zhang, X.-Y., Chen, Z., Yao, J., Wu, K.-X., Zhong, W.-Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678666
Bao, Q., Xia, M.-Z., Xiong, J., Liu, Y.-W., Li, Y.-Q., Zhang, X.-Y., Chen, Z., Yao, J., Wu, K.-X., Zhong, W.-Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678669
Bao, Q., Xia, M.-Z., Xiong, J., Liu, Y.-W., Li, Y.-Q., Zhang, X.-Y., Chen, Z., Yao, J., Wu, K.-X., Zhong, W.-Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678672
Bao, Q., Xia, M.-Z., Xiong, J., Liu, Y.-W., Li, Y.-Q., Zhang, X.-Y., Chen, Z., Yao, J., Wu, K.-X., Zhong, W.-Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678663
Gallagher, D., Kang, Y., Herrmann, N., Kiss, A., Black, S. E., Oh, P., Marzolini, S., Rabin, J. S., Andreazza, A. C., Ramirez, J., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02062-z
BindingDB Entry 50020539: The evolution of small molecule enzyme activators.
BindingDB (2024) · UC San Diego · doi:10.7270/q2b56q63
Metadata
- Authors
- Bennett, S., Grant, M. M., & Aldred, S.
- Affiliations
- University of Birmingham (GB)
- Corresponding author
- Aldred, Sarah
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2008-11-10
- Volume
- 17
- Issue
- 2
- Pages
- 245-257
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1900968643
- Cited by
- 254
- References
- 0
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 28 · 2023: 19 · 2022: 20 · 2021: 27 · 2020: 14 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 12 · 2015: 15 · 2014: 12 · 2013: 8 · 2012: 12
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- oxidative stress, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Humans, Dementia, Vascular, Amyloid beta-Peptides, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.